tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Omega Therapeutics reports Q3 revenue $2.61M, consensus $1.34M

As of September 30, the company had cash and cash equivalents totaling $30.4M, which is expected to fund operations into Q2 2025.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1